Very early researchStudy completedNCT06541093
What this trial is testing
Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.
Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections
Uvax Bio LLC 34